Edwards Lifesciences

Edwards Lifesciences Overview

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Edwards Israel Innovation Center (EIIC) serves as the Israeli R&D center. The office was opened after the acquisition of Percutaneous Valve Technologies in 2003 and it focuses on developing early-stage cardiovascular technologies.

Latest News

Oct 7, 2025 · finance.yahoo.com

growth-positive

Netflix upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

Jefferies upgraded AMD to Buy from Hold, raising the price target from $170 to $300. This upgrade is driven by OpenAIs plans to purchase six gigawatts of AMD equipment, which significantly changes AMDs AI narrative. The acquisition of such a large volume of equipment by OpenAI is expected to positively impact AMDs growth, reflecting the companys strong position in the AI technology market. The upgrade suggests confidence in AMDs potential for continued momentum and growth in the AI sector.

Customers

Jul 15, 2024 · en.globes.co.il

growth-positive

Edwards Lifesciences buys Israeli co Innovalve Bio Medical

Edwards Lifesciences has announced its intention to acquire Israeli medical device company Innovalve Bio Medical. The financial details of the acquisition have not been disclosed, but it is estimated to be worth hundreds of millions of dollars. Innovalve, which was founded at Sheba Medical Center, has previously signed a technology agreement with Edwards Lifesciences. The acquisition is expected to enhance Edwards trans-catheter mitral valve replacement technologies and support its long-term growth. Innovalve will join Edwards trans-catheter mitral and tricuspid therapies product group.

Acquisition

Oct 7, 2021 · en.globes.co.il

growth-positive

"Medicine is going to become much less invasive"

The article discusses Edwards Lifesciences, a US company that specializes in heart valves. The company acquired Israeli company PVT in 2004, which added a leading heart valve product to its offerings. Edwards still maintains a development center in Israel and has doubled its workforce since the acquisition. The company is focused on innovation and is looking for more acquisitions and collaborations in Israel. Edwards recently signed a deal with CollPlant, an Israeli company that develops products based on human collagen. The companies are working on a collagen-based component for heart valves, which could be worth tens of millions of dollars. Edwards has a market cap of $10 billion and annual sales of $1.4 billion. The CEO believes in the future of minimally invasive procedures and improving healthcare technology in developing countries.

AcquisitionPartners

Dec 23, 2018 · www.ocregister.com

growth-positive

Most Influential 2018: Edwards Lifesciences CEO Mike Mussallem leads company making medical breakthroughs

Edwards Lifesciences CEO Mike Mussallem has transformed the company from a debt-ridden spinoff into a leading manufacturer of replacement heart valves. Over the past 18 years, the companys value has increased by 4,000%, employment has doubled to nearly 13,000 in 40 nations, and its Irvine headquarters has expanded to 11 buildings on 40 acres. Mussallem has also been named to the Harvard Business Reviews list of the worlds best-performing CEOs four times in the past five years. In addition to its business success, Edwards Lifesciences is also committed to giving back to the community.

Management ChangesExpand

Nov 28, 2016 · www.globes.co.il

growth-positive

Edwards buys Israeli co Valtech Cardio for $1b

US company Edwards Lifesciences Corporation is acquiring Israeli valve repair device company Valtech Cardio Ltd. Edwards will pay Valtech $340 million in stock and cash at closing, with the potential for up to $350 million in milestone payments over the next 10 years and $300 million more for Valtechs early-stage transseptal mitral valve replacement technology program. The Cardioband System combines a reconstruction implant, similar to a surgical annuloplasty mitral valve repair device, with a transcatheter approach.

Acquisition

Team Members

3

Employees: 51-200

Web & Social Links

Locations

Tel Aviv-Yafo, Israel

HaTohen Street 17, Caesarea, Israel

Derech Menachem Begin 121, Tel Aviv-Yafo, Israel

Irvine, CA, USA

Photos & Videos

No files yet

Edwards Lifesciences Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info